Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Nicox logo — Maintain vision and improve ocular health

Nicox

Maintain vision and improve ocular health

Founded 1996 France France 46 employees Post Ipo Equity Total: $197.30M Biotechnology, Health Care +1

General Information

Company Name Nicox
Founded Year 1996
Location France France +3
Employees 46
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Post Ipo Equity
Social

Get notified when Nicox moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Nicox

Nicox, an international ophthalmic R&D company, has been dedicated to maintaining vision and improving ocular health since its establishment in 1996. With a focus on biotechnology, healthcare, and medical devices, the company is committed to building a diversified portfolio of therapeutic products to meet the needs of eyecare practitioners and patients globally. Nicox's global growth strategy revolves around outstanding international collaborations and its proprietary programs, including those from its nitric oxide-donating research platform. The most recent development for Nicox took place on July 18, 2024, with a €3.30M Post-IPO Equity investment. This investment, although not disclosed with specific investors, signifies a potential milestone for the company. The headquarter of Nicox is located in France. For further information, individuals can visit their website at www.nicox.com.

Taxonomy: biopharmaceuticals, ophthalmology, nitric oxide-donating drugs, inflammation, cardiovascular diseases, osteoarthritis, glaucoma treatment, respiratory disorders, allergic rhinitis, hypertension treatment, skin disorders, diabetic retinopathy, collaborations, drug development

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• - 18 Jul 2024
Post-IPO Equity •••••• - 22 Nov 2022
Post-IPO Equity •••••• - 09 Dec 2021
Post-IPO Debt •••••• 1
Investor
25 Jan 2019
Post-IPO Equity •••••• - 18 Nov 2009

Nicox Alternatives & Competitors

Nicox vs
The Ranch TN
The Ranch TN United States

The Ranch provides a highly effective, one-of-a-kind recovery experience for men and women strugglin...

31 employees
Care Economy, Health Care
Compare Nicox vs The Ranch TN
Nicox vs
ENT Specialists Inc.
ENT Specialists Inc. United States

Improving ENT health for Patients in SouthEastern MA and RI for over 50 Years!

23 employees
Care Economy, Health Care
Compare Nicox vs ENT Specialists Inc.
Nicox vs
Neuronetics, Inc.
Neuronetics, Inc. United States

Non-drug, safe, effective treatment for depression and other mental health conditions.

Post Ipo Debt
220 employees
Biotechnology, Health Care
Compare Nicox vs Neuronetics, Inc.

FAQ About Nicox

Maintain vision and improve ocular health
Nicox was founded in 1996.
Nicox is headquartered in France.
Nicox operates in the following industries: Biotechnology, Health Care, Medical Devices.
Nicox has approximately 46 employees.
Nicox has completed 5 funding rounds, raising a total of $197.30M. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to Nicox include The Ranch TN, ENT Specialists Inc., Neuronetics, Inc., Bright Therapeutics, GI Diagnostics Endoscopy Center. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Nicox and The Ranch TN are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Nicox and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy